On October 20, 2022, we held a panel discussion highlighting the lingering effects of COVID-19, commonly known as Long COVID or post-acute sequelae of SARS-CoV-2 infection (PASC). This term encapsulates a range of persistent symptoms that endure for weeks or even months after the initial acute phase of a COVID-19 infection.
Long COVID manifests across various organ systems, presenting individuals with ongoing challenges such as fatigue, difficulty concentrating (often described as “brain fog”), shortness of breath, and other lingering health issues. Unraveling the complexities of these prolonged symptoms is crucial for providing effective medical care and support.
The Centers for Disease Control and Prevention (CDC) have played a pivotal role in studying and comprehending the long-term effects of COVID-19. Employing various tools, including surveys, the CDC gathers essential data on the prevalence and characteristics of Long COVID. One noteworthy tool is the House Pulse Survey, conducted in collaboration with federal agencies, which offers timely insights into the social and economic impacts of the ongoing pandemic.
